Ultragenyx Pharmaceutical Files 8-K on Financials
Ticker: RARE · Form: 8-K · Filed: May 6, 2025 · CIK: 1515673
| Field | Detail |
|---|---|
| Company | Ultragenyx Pharmaceutical Inc. (RARE) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: UGNX
TL;DR
UGNX filed an 8-K on May 6th detailing financial results. Check it for the latest numbers.
AI Summary
Ultragenyx Pharmaceutical Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's financial performance. The company is incorporated in Delaware and headquartered in Novato, California.
Why It Matters
This 8-K filing provides investors with crucial updates on Ultragenyx Pharmaceutical's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Ultragenyx Pharmaceutical Inc. (company) — Registrant
- May 06, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Novato, California (location) — Principal Executive Offices
- 415 483-8800 (phone_number) — Registrant's Telephone Number
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on May 06, 2025.
Where is Ultragenyx Pharmaceutical Inc. headquartered?
The company's principal executive offices are located at 60 Leveroni Court, Novato, California, 94949.
What is the SEC file number for Ultragenyx Pharmaceutical Inc.?
The SEC file number is 001-36276.
What is the standard industrial classification for Ultragenyx Pharmaceutical Inc.?
The standard industrial classification is PHARMACEUTICAL PREPARATIONS [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Ultragenyx Pharmaceutical Inc. (RARE).